Pharmaceutical Industry Information Portal

HomeTagsUnicorn Capital Partners

All posts by tag

Unicorn Capital Partners

New investments in the innovative biotechnology company “Target Medicals”

RDIF, AstraZeneca and Unicorn Capital Partners invest in Target Medicals, developing aldosterone synthase inhibitor for the treatment of resistant arterial hypertension. The Russian Direct Investment...

Expert Articles